ERIS LIFESCIENCES
|
The Current P/S Ratio of ERIS LIFESCIENCES is 7.34.
Share Price | ₹1,476.7 | Feb 07,2025 |
Market Cap | ₹20,097.9 Cr | |
Sales-TTM | ₹2,739.3 Cr | TTM-Consolidated Results |
Price/Sales | 7.34x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ERIS LIFESCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹20,097.9 Cr] as on Feb 07,2025
(/) Sales [ ₹2,739.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.34x ]
Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay '7.34 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ERIS LIFESCIENCES !
The chart below summarizes the trend in P/S Ratio of ERIS LIFESCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of ERIS LIFESCIENCES
PS Ratio Performance Analysis for ERIS LIFESCIENCES
- ERIS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.74x.
- ERIS LIFESCIENCES 's operated at median p/e ratio of 5.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/e ratio peaked in Mar2022 at 6.95x.
- ERIS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 4.62x.
How does ERIS LIFESCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ERIS LIFESCIENCES | 2,739.3 | 7.34 | 20,097.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 8.13 | 419,764.0 |
CIPLA LTD | 26,981.2 | 4.41 | 118,905.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.31 | 103,523.0 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.50 | 100,015.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 17.96 | 163,010.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.93 | 103,904.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.76 | 110,313.0 |
LUPIN LTD | 21,431.3 | 4.68 | 100,405.0 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.24 | 69,214.1 |
ABBOTT INDIA LTD | 6,243.2 | 10.14 | 63,315.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ERIS LIFESCIENCES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.24x |
Max industry PS | 17.96x |
Median industry PS | 7.34x |
Average industry PS | 7.40x |
You may also like the below Video Courses